Page last updated: 2024-08-24

n-methylnicotinamide and Diabetic Nephropathies

n-methylnicotinamide has been researched along with Diabetic Nephropathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burns, WC; Cao, Z; Cooper, ME; Forbes, JM; Ghabrial, H; Jerums, G; Kantharidis, P; Osicka, TM; Russo, LM; Thallas, V; Thomas, MC; Tikellis, C	1

Other Studies

1 other study(ies) available for n-methylnicotinamide and Diabetic Nephropathies

Article	Year
Reduced tubular cation transport in diabetes: prevented by ACE inhibition. Kidney international, 2003, Volume: 63, Issue:6 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Cations; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Kidney Tubules; Male; Niacinamide; Organic Cation Transport Proteins; Ramipril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger	2003

Article

Year

Reduced tubular cation transport in diabetes: prevented by ACE inhibition.

Kidney international, 2003, Volume: 63, Issue:6

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Cations; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Kidney Tubules; Male; Niacinamide; Organic Cation Transport Proteins; Ramipril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger

2003